docetaxel
Showing 1 - 25 of 1,239
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial (Standard ADT (androgen deprivation therapy), Standard Darolutamide,
Not yet recruiting
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- Standard ADT (androgen deprivation therapy)
- +2 more
- (no location specified)
Jan 6, 2023
Hyperthermic Intraperitoneal Chemo Trial in Guangzhou (Docetaxel)
Recruiting
- Hyperthermic Intraperitoneal Chemotherapy
- Docetaxel
-
Guangzhou, Other (Non U.s.), ChinaSun Yat-sen Memorial Hospital
Jun 6, 2022
Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,
Recruiting
- Hormone Sensitive Metastatic Prostate Cancer
- +3 more
- Docetaxel
- +2 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022
NSCLC Trial (Pembrolizumab, Docetaxel)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Pembrolizumab
- Docetaxel
- (no location specified)
Aug 18, 2022
Breast Cancer Trial in Beijing (QL1701, Herceptin®, Docetaxel)
Active, not recruiting
- Breast Cancer
- QL1701
- +2 more
-
Beijing, ChinaCancer Hospital,Chinese Academy of Medical Sciences
Nov 18, 2022
Breast Cancer, Chemo Effect Trial (Nab paclitaxel, Docetaxel)
Not yet recruiting
- Breast Cancer
- Chemotherapy Effect
- Nab paclitaxel
- Docetaxel
- (no location specified)
Feb 11, 2022
Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (utidelone, docetaxel)
Not yet recruiting
- Breast Neoplasms
- Locally Advanced or Metastatic Breast Cancer
- utidelone
- docetaxel
-
Guangzhou, Gangdong, ChinaShusen Wang
Jun 21, 2022
Effect of Drug Trial in Sapporo (Docetaxel, Pembrolizumab)
Not yet recruiting
- Effect of Drug
- Docetaxel
- Pembrolizumab
-
Sapporo, Hokkaido, JapanHokkaido University Hospital
Feb 12, 2022
Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)
Active, not recruiting
- Prostate Cancer
- +2 more
- PROSTVAC-V
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)
Completed
- Prostate Cancer
- docetaxel
- sorafenib tosylate
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 16, 2022
Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)
Recruiting
- Cancer Of Prostate
- Prostate Neoplasms
- ADT
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)
Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)
Recruiting
- Head and Neck Squamous Carcinoma
- SCT-I10A
- +3 more
-
Shanghai, ChinaShanghai East Hospital
Sep 22, 2022
Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)
Recruiting
- Soft Tissue Sarcoma
- Gemcitabine
- +4 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Mar 7, 2022
Nsclc Trial in Beijing (HL-085, Docetaxel)
Terminated
- Nsclc
- HL-085
- Docetaxel
-
Beijing, ChinaCancer Hospital Chinese Academy of Medical Science
Nov 29, 2021
Non Small Cell Lung Cancer (NSCLC) Trial in United States (SPI-1620, Docetaxel)
Terminated
- Non Small Cell Lung Cancer (NSCLC)
- SPI-1620
- Docetaxel
-
Cincinnati, Ohio
- +4 more
Oct 8, 2021
Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine
- +2 more
- (no location specified)
Sep 9, 2022
NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)
Terminated
- Non-small Cell Lung Cancer
- Pevonedistat
- Docetaxel
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 16, 2021
Non Small Cell Lung Cancer Trial in Davis, Orlando, Columbus (ONC-392, Docetaxel)
Not yet recruiting
- Non Small Cell Lung Cancer
- ONC-392
- Docetaxel
-
Davis, California
- +2 more
Jan 5, 2023
Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))
Active, not recruiting
- Prostatic Neoplasm
- Docetaxel
- Androgen-Deprivation Therapy (ADT)
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 6, 2022
Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)
Recruiting
- Recurrent Non-small Cell Lung Cancer
- Cisplatin
- +7 more
-
Changchun, Jilin, China
- +2 more
May 3, 2022
Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)
Not yet recruiting
- Breast Cancer
- Pyrotinib
- +7 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Dec 2, 2022